REPROCELL have signed a Strategic Collaboration Agreement with TEXCELL JAPAN. The TEXCELL Group is a contract manufacturing organization (CMO) headquartered in France and managed by the holding company Soparbiotech International. REPROCELL has established manufacturing pipeline for GMP iPSC MCBs in accordance with the guidelines of the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. REPROCELL can outsource part of the MCB manufacturing process at TEXCELL's GMP facility, certified by EMA, enabling the establishment of GMP iPSC MCB. This Strategic Collaboration Agreement supplements the earlier signed Master Service Agreement and strengthens the relationship with TEXCELL as a strategic partner in generating GMP iPSC - Master Cell Bank for REPROCELL clients globally.